Cytosorbents Corp. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,183.00
5,549.80
7,508.90
5,245.20
17,321.90
22,368.80
Total Accounts Receivable
453.00
819.20
648.90
1,433.50
2,205.90
3,943.10
Inventories
245.60
537.60
1,190.70
834.00
795.70
833.10
Other Current Assets
605.30
700.50
511.90
315.80
416.00
1,119
Total Current Assets
3,487.00
7,607.00
9,860.30
7,828.40
20,739.30
28,264.10
Net Property, Plant & Equipment
144.40
245.80
557.30
569.40
1,402.80
1,729.90
Total Investments and Advances
-
58.30
-
-
-
-
Intangible Assets
360.50
557.50
771.80
1,191.10
1,838.10
2,625.30
Other Assets
53.90
-
65.00
104.90
123.10
128.10
Total Assets
4,045.70
8,468.60
11,254.40
9,693.80
24,103.30
32,747.30
ST Debt & Current Portion LT Debt
1,644.40
-
-
833.30
4,000.00
Accounts Payable
786.50
698.30
684.60
1,374.90
1,566.80
Income Tax Payable
-
-
22.60
96.20
452.40
Other Current Liabilities
634.10
3,807.10
2,336.60
1,973.60
1,829.20
Total Current Liabilities
3,064.90
4,505.40
3,043.80
4,278.10
7,848.30
Long-Term Debt
-
-
-
4,078.30
5,992.10
Total Liabilities
3,064.90
4,505.40
3,043.80
8,356.40
13,840.50
Common Equity (Total)
14,267.30
3,963.20
8,210.60
1,337.50
10,262.80
Total Shareholders' Equity
980.80
3,963.20
8,210.60
1,337.50
10,262.80
Total Equity
980.80
3,963.20
8,210.60
1,337.50
10,262.80
Liabilities & Shareholders' Equity
4,045.70
8,468.60
11,254.40
9,693.80
24,103.30
Preferred Stock (Carrying Value)
15,248.10
-
-
-
-
About Cytosorbents
View Profile
